Earnings Per Share, Basic of PharmaCyte Biotech, Inc. from 31 Jul 2010 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
PharmaCyte Biotech, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Jul 2010 to 31 Oct 2025.
  • PharmaCyte Biotech, Inc. Earnings Per Share, Basic for the quarter ending 31 Oct 2025 was -1.24, a 218% decline year-over-year.
  • PharmaCyte Biotech, Inc. Earnings Per Share, Basic for the twelve months ending 31 Oct 2025 was -0.79, a 255% decline year-over-year.
  • PharmaCyte Biotech, Inc. annual Earnings Per Share, Basic for 2024 was 3.19.
  • PharmaCyte Biotech, Inc. annual Earnings Per Share, Basic for 2023 was -1.8, a 718% decline from 2022.
  • PharmaCyte Biotech, Inc. annual Earnings Per Share, Basic for 2022 was -0.22, a 19% increase from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

PharmaCyte Biotech, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 -0.79 -1.24 -0.85 -218% 01 Aug 2025 31 Oct 2025 10-Q 18 Dec 2025 2026 Q2
Q2 2025 0.06 -1.23 -3.13 -165% 01 May 2025 31 Jul 2025 10-Q 15 Sep 2025 2026 Q1
Q1 2025 3.19 2.12 +2.47 01 Feb 2025 30 Apr 2025 10-K 11 Aug 2025 2025 FY
Q4 2024 0.72 -0.44 +0.21 +32% 01 Nov 2024 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 0.51 -0.39 -0.13 -50% 01 Aug 2024 31 Oct 2024 10-Q 18 Dec 2025 2026 Q2
Q2 2024 0.64 1.9 +2.44 01 May 2024 31 Jul 2024 10-Q 15 Sep 2025 2026 Q1
Q1 2024 -1.8 -0.35 -0.33 -1650% 01 Feb 2024 30 Apr 2024 10-K 11 Aug 2025 2025 FY
Q4 2023 -1.47 -0.65 -0.61 -1525% 01 Nov 2023 31 Jan 2024 10-Q 17 Mar 2025 2025 Q3
Q3 2023 -0.86 -0.26 -0.17 -189% 01 Aug 2023 31 Oct 2023 10-Q 13 Dec 2024 2025 Q2
Q2 2023 -0.69 -0.54 -0.47 -671% 01 May 2023 31 Jul 2023 10-Q 17 Sep 2024 2025 Q1
Q1 2023 -0.22 -0.02 -0.49 -104% 01 Feb 2023 30 Apr 2023 10-K 13 Aug 2024 2024 FY
Q4 2022 0.27 -0.04 0 0% 01 Nov 2022 31 Jan 2023 10-Q 18 Mar 2024 2024 Q3
Q3 2022 0.27 -0.09 -0.03 -50% 01 Aug 2022 31 Oct 2022 10-Q 15 Dec 2023 2024 Q2
Q2 2022 0.3 -0.07 +0.57 +89% 01 May 2022 31 Jul 2022 10-Q 18 Sep 2023 2024 Q1
Q1 2022 -0.27 0.47 01 Feb 2022 30 Apr 2022 10-K 31 Jul 2023 2023 FY
Q4 2021 -0.04 01 Nov 2021 31 Jan 2022 10-Q 16 Mar 2023 2023 Q3
Q3 2021 -0.06 01 Aug 2021 31 Oct 2021 10-Q 14 Dec 2022 2022 Q2
Q2 2021 -0.64 01 May 2021 31 Jul 2021 10-Q 14 Sep 2022 2023 Q1
Q4 2014 -0.04 0 0 01 Nov 2014 31 Jan 2015 10-Q 13 Mar 2015 2015 Q3
Q3 2014 -0.04 -0.01 0 0% 01 Aug 2014 31 Oct 2014 10-Q 15 Dec 2014 2015 Q2
Q2 2014 -0.04 0 +0.01 01 May 2014 31 Jul 2014 10-Q 15 Sep 2014 2015 Q1
Q1 2014 -0.05 -0.03 -0.03 01 Feb 2014 30 Apr 2014 10-K 04 Aug 2014 2014 FY
Q4 2013 -0.02 0 0 01 Nov 2013 31 Jan 2014 10-Q 13 Mar 2015 2015 Q3
Q3 2013 -0.02 -0.01 -0.01 01 Aug 2013 31 Oct 2013 10-Q 15 Dec 2014 2015 Q2
Q2 2013 -0.01 -0.01 -0.01 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014 2015 Q1
Q1 2013 0 0 +0.01 01 Feb 2013 30 Apr 2013 10-K 04 Aug 2014 2014 FY
Q4 2012 -0.01 0 0 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014 2014 Q3
Q3 2012 -0.01 0 0 01 Aug 2012 31 Oct 2012 10-Q 16 Dec 2013 2014 Q2
Q2 2012 -0.01 0 0 01 May 2012 31 Jul 2012 10-Q 16 Sep 2013 2014 Q1
Q1 2012 -0.01 -0.01 -0.01 01 Feb 2012 30 Apr 2012 10-K 29 Jul 2013 2013 FY
Q4 2011 0 0 0 01 Nov 2011 31 Jan 2012 10-Q 26 Mar 2013 2013 Q3
Q3 2011 0 0 0 01 Aug 2011 31 Oct 2011 10-Q 26 Dec 2012 2013 Q2
Q2 2011 0 0 0 01 May 2011 31 Jul 2011 10-Q 19 Sep 2012 2013 Q1
Q1 2011 0 0 01 Feb 2011 30 Apr 2011 10-K 14 Aug 2012 2012 FY
Q4 2010 0 01 Nov 2010 31 Jan 2011 10-Q 21 Mar 2012 2012 Q3
Q3 2010 0 01 Aug 2010 31 Oct 2010 10-Q 15 Dec 2011 2012 Q2
Q2 2010 0 01 May 2010 31 Jul 2010 10-Q/A 20 Sep 2011 2012 Q1

PharmaCyte Biotech, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 3.19 +4.99 01 May 2024 30 Apr 2025 10-K 11 Aug 2025 2025 FY
2023 -1.8 -1.58 -718% 01 May 2023 30 Apr 2024 10-K 11 Aug 2025 2025 FY
2022 -0.22 +0.05 +19% 01 May 2022 30 Apr 2023 10-K 13 Aug 2024 2024 FY
2021 -0.27 +2.18 +89% 01 May 2021 30 Apr 2022 10-K 31 Jul 2023 2023 FY
2020 -2.45 01 May 2020 30 Apr 2021 10-K 28 Jul 2022 2022 FY
2013 -0.05 -0.05 01 May 2013 30 Apr 2014 10-K 04 Aug 2014 2014 FY
2012 0 +0.01 01 May 2012 30 Apr 2013 10-K 04 Aug 2014 2014 FY
2011 -0.01 -0.01 01 May 2011 30 Apr 2012 10-K 29 Jul 2013 2013 FY
2010 0 01 May 2010 30 Apr 2011 10-K 14 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.